Simultaneous blockade of Tim-3 and PD-1 could effectively restore the antitumor activity of these exhausted T cells, resulted in complete tumor regression, and remained tumor free even after rechallenge [17]. The gene discussed is HAVCR2; the disease is neoplasm.